[ad_1] The FDA approved tafenoquine (Krintafel) for the "radical cure" of malaria in Plasmodium vivax in patients aged 16 years and older receiving antimalarial treatment for acute infection, the manufacturer said GlaxoSmithKline …
Read More »FDA Approves Single-Dose Malaria Drug
